These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2093422)

  • 21. Pharmacological features of an almitrine-raubasine combination. Activity at cerebral levels.
    Benzi G
    Eur Neurol; 1998; 39 Suppl 1():31-8. PubMed ID: 9516073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-blind, placebo-controlled quantitative EEG and psychometric studies in elderlies on vigilance-promoting effects of an almitrine/raubasine combination (Duxil).
    Saletu B; Grünberger J; Linzmayer L; Anderer P
    Arch Gerontol Geriatr; 1988 Jun; 7(2):93-110. PubMed ID: 3415398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stability-indicating methods for the determination of a mixture of almitrine and raubasine by derivative spectrophotometry.
    El-Sayed MA
    Drug Test Anal; 2009 Jun; 1(6):279-85. PubMed ID: 20355207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Almitrine-Raubasine combination for dementia.
    Yang W; Liu M; Teng J; Hao Z; Wu B; Wu T; Liu GJ
    Cochrane Database Syst Rev; 2011 Mar; (3):CD008068. PubMed ID: 21412915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Quantified electroencephalogram: value in the evaluation of therapy of cerebral aging].
    Sebban C; Tesolin B; Guez D
    Presse Med; 1987 Jun; 16(23):1154-8. PubMed ID: 2885826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Metabolic and blood circulation evaluation of acute ischemic cerebral accident in humans using positron emission tomography].
    Depresseux JC; Franck G; Van Cauwenberge H
    Presse Med; 1987 Jun; 16(23):1145-50. PubMed ID: 2885825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurologic and histologic evaluation of almitrine+raubasine (Duxil) in middle cerebral artery occlusion in cats.
    Chan P; Li Y; Zheng Z; Hu P; Sarbach SD; Guez D
    Eur J Pharmacol; 1993 Feb; 231(2):175-82. PubMed ID: 8453973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of a tissue oxygenator (almitrine + raubasine) on the metabolism of 2,3-diphosphoglycerate of rabbits submitted by hypoxia].
    Callis A; Dorance M; Magnan de Bornier B
    C R Seances Soc Biol Fil; 1980; 174(6):1006-9. PubMed ID: 6451260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Demonstration of the therapeutic activity of 5023 SE on intellectual and psychomotor efficacy in elderly impaired patients. Double-blind controlled study versus placebo].
    Berthaux P; Laforestrie R
    Presse Med; 1983 Mar; 12(13):852-5. PubMed ID: 6220336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental approach of treatment of cerebral ischemia by a combination of raubasine and almitrine.
    Borzeix MG; Cahn J
    Arzneimittelforschung; 1987 May; 37(5):491-4. PubMed ID: 2887170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of 5023 SE on PaO2 at rest in elderly patients with cerebral impairment. A double-blind cross-over trial versus placebo].
    Memin Y
    Presse Med; 1983 Mar; 12(13):849-51. PubMed ID: 6220335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A multicenter study of tinnitus. Epidemiology and therapy].
    Meyer B
    Ann Otolaryngol Chir Cervicofac; 1986; 103(3):185-8. PubMed ID: 3530094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evidence for the action of raubasine from a new formulation of Lamuran tablets].
    Glocke M; Grübl M; Klein K; Teufel W
    Med Klin; 1976 Sep; 71(38):1564-8. PubMed ID: 790125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind placebo controlled clinical trial of almitrine bismesylate in patients with chronic respiratory insufficiency.
    Bakran I; Vrhovac B; Stangl B; Tabori D; Ivicevic A; Todic V; Kandare F
    Eur J Clin Pharmacol; 1990; 38(3):249-53. PubMed ID: 2187700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Almitrine bismesylate: a long-term placebo-controlled double-blind study in COAD--Vectarion International Multicentre Study Group.
    Voisin C; Howard P; Ansquer JC
    Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():169s-182s. PubMed ID: 3318971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dihydroergocristine in organic brain psychosyndrome. Multicenter placebo-controlled clinical double-blind study in 240 patients].
    Lazzaroni M; Cattalini C; Massetto N; Poli A
    Arzneimittelforschung; 1992 Nov; 42(11A):1410-3. PubMed ID: 1492864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of synaptosomal enzymatic alterations and drug treatment in brain aging.
    Curti D; Benzi G
    Clin Neuropharmacol; 1990; 13 Suppl 3():S59-72. PubMed ID: 1965531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of raubasine and dihydroergocristine on an age-related deficit in passive avoidance learning in rats.
    Chopin P; Briley M
    J Pharm Pharmacol; 1990 May; 42(5):375-6. PubMed ID: 1976794
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effects of aging and various pharmacologic agents on the brain energy metabolism in the course of post-hypoglycemic recuperation in the rat].
    Villa RF; Pastoris O
    Presse Med; 1987 Jun; 16(23):1128-34. PubMed ID: 2885824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Almitrine bismesylate and oxygen therapy in hypoxic cor pulmonale.
    Evans TW; Tweney J; Waterhouse JC; Nichol J; Suggett AJ; Howard P
    Thorax; 1990 Jan; 45(1):16-21. PubMed ID: 2108510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.